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The Journal of Craniofacial Surgery  Volume 29, Number 3, May 2018Abstract: Bones with different embryological origin and mode of
ossification are supposed to vary in their capacity for supporting graft
consolidation. The aim of the current pilot study was to assess the
TGF-b1 activity of bone chips obtained from distinct anatomic
locations. Conditioned medium was prepared from bone chips har-
vested from pig calvaria, mandible, and tibia. Human oral fibroblasts
were exposed to bone-conditioned medium (BCM) followed by
reverse transcriptase polymerase chain reaction of the TGF-b1 target
genes. Also an immunoassay for interleukin 11 (IL-11) and TGF-b1
was performed. The impact of BCMon alkaline phosphatase activity
was determined with murine MC3T3-E1 osteogenic cells. The
authors report here that BCM contains TGF-b1 in the ng/mL range.
Bone chips prepared from pig calvaria, mandible, and tibia femur had
a similar capacity for increasing the expression of the TGF-b1 target
genes IL-11, NOX4, and PRG4. Correspondingly, immunoassays
revealed similar production of IL-11 by human oral fibroblasts.
Furthermore, conditioned medium obtained from the 3 bones
decreased alkaline phosphatase activity in MC3T3-E1 osteogenic
cells. These preliminary data demonstrate that particulated bone
grafts, regardless of embryological origin, mode of ossification
and morphology, release a similar TGF-b1 activity.
Key Words: Allografts, augmentation, bone regeneration, in vitro,
TGF-b1
(J Craniofac Surg 2018;29: 553–557)B one grafting is a common procedure for bone restoration invarious fields of reconstructive surgery including those of oral
and maxillofacial surgery as well as implant dentistry. Bone grafts
can be harvested from various donor sites, including calvaria,1–4
mandible,1–4 and tibia,5,6 referred to as regional7 and distant sites,8
respectively. Cortical bone can be applied as block grafts or as bone
chips when milled or harvested with a bone scraper.9 Block grafts
are used for augmentations requiring screw fixation, while bone
chips are used to fill containing defects and to reshape the contour.
Processing of grafts into bone blocks or bone chips affects the
process of graft consolidation; for example, bone blocks have a
slower resorption rate compared with bone chips.9,10 However,
there is a debate whether the donor site affects the behavior of bone
grafts during the consolidation process.
It is a widely held belief that embryological origin and mode of
ossification affect the clinical properties of bone grafts.4,11,12 At the
mandibular base and the alveolar process, Meckel cartilage guides
mesenchymal cells originating from the ectodermal neural crest to
undergo intramembranous or direct ossification.13 The flat bones of
the cranial vault originate from unsegmented paraxial mesoderm
and the neural crest, again by intramembranous ossification.13 In
both developmental processes, epithelial cells have to undergo a
transition into mesenchymal cells, which can form bone. The tibia,
however, originates from the lateral plate mesoderm where mesen-
chymal cells form cartilage that undergoes endochondral bone
formation.14 Considering that all bones undergo bone remodeling,
the material properties might become similar and independent from
developmental aspects.
In our previous studies, we have introduced a bioassay to
evaluate the paracrine-like activity of bone chips,15,16 in addition
to proteomic analysis of the conditioned medium.17 This bioassay
reflects the activity of TGF-b released from freshly prepared bone
chips or from bone chips undergoing heating,18 radiation,19 and
exposure to antiseptic solutions.20 The TGF-b activity is repre-
sented by the expression of TGF-b target genes including interleu-
kin 11 (IL-11), proteoglycan 4 (PRG4), and NADPH oxidase 4
(NOX4), all of which play a possible role during bone regeneration
and thus graft consolidation. Interleukin 11 is a member of the IL-6
family of cytokines and, together with BMP-2, can accelerate bone
regeneration.21 PRG4 is expressed in the superficial zone of articu-
lar cartilage22 and supports endochondral bone formation.23 NOX4
generates intracellular superoxide which also modulates osteoblasts
BMP-2 activity.24 Thus, the genes that are regulated by TGF-b
activity within bone-conditioned medium (BCM) can target bone
cells and theoretically translate into a cellular response that is
relevant in graft consolidation.
TGF-b is a central regulator of bone regeneration and remodel-
ing. Reports examined the expression of TGF-b and the respective
receptors during fracture healing such as during mandibular dis-
traction osteogenesis.25 The function of TGF-b in this process,
however, is poorly understood. TGF-b2 acts specifically duringion of this article is prohibited.
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FIGURE 1. Bone-conditioned medium from the 3 preparations of bone chips
increases expression of TGF-b target genes. Fibroblasts were exposed to
conditioned medium prepared from bone chips harvested from calvaria,
mandible, and tibia. Expression of the TGF-b target genes was determined by
reverse transcription polymerase chain reaction. Data represent the results of 3
independent preparations of bone-conditioned medium exposed to 3
independent lines of gingiva fibroblasts ending up with n¼6 for each group.
The nonparametric Friedman test was used to detect differences in treatment
groups with a P<0.05.
Hatami Kia et al The Journal of Craniofacial Surgery  Volume 29, Number 3, May 2018fracture healing to stimulate the migration of osteoblasts as well as
the differentiation of osteoblasts and osteoclasts.26 On the other
hand, loss of TGF-b/Smad3 signaling stimulated callus formation
by promoting osteogenesis and suppressing chondrogenesis, result-
ing in faster fracture healing.27 Locally applied TGF-b1 improves
the mineral density of distraction gap and load to failure,28 and the
use of demineralized bonematrix along with TGF-b1 can accelerate
bone repair in a tibia fracture open osteotomy model.29 TGF-b
activity within BCMmay have an impact on bone regeneration, and
it is thus of possible relevance to determine whether the donor site
affects the paracrine-like activity of bone grafts.
The goal of the current study is to assess whether there is a
difference between embryological origin of various bone grafts on
their function by using to TGF-b1 activity.
MATERIALS AND METHODS
Bone-Conditioned Medium
Bone-conditioned medium was prepared as originally described
by Peng et al.15 In brief, bone was obtained from adult pigs within
6 hours postmortem (Fleischerei Leopold Ho¨dl, Vienna, Austria).
Bone chips were harvested at room temperature under aseptic
conditions from 3 sources: calvaria, mandible, and tibia with a
bone scraper (Hu-Friedy, Rotterdam, The Netherlands). Bone chips
were placed into sterile plastic dishes containing Dulbecco modi-
fied Eagle medium (DMEM) supplemented with antibiotics and
antimycotics (all from Invitrogen Corporation, Carlsbad, CA). Five-
gram bone chips were incubated with 10 mL serum-free culture
medium (50% weight/volume). Bone-conditioned medium was
harvested after 24 hours of incubation at 378C in a humidified
atmosphere at 5% carbon dioxide. Bone-conditioned medium
was filtered sterile and kept frozen at 808C. The stocks were
thawed immediately before each experiment. The concentration of
human TGF-b1 in BCM was measured with an ELISA kit (R&D
Systems, Minneapolis, MN).
Primary Gingival Fibroblasts and MC3T3-E1
Cells
Human gingival fibroblasts were prepared from explant cultures
of 3 independent donors after approval of the ethical committee of
the Medical University of Vienna (EK No 631/2007). Patients
consented for obtaining and using gingival fibroblasts from their
tissue. Murine osteogenic MC3T3-E1 cells were kindly provided by
Oskar Hoffman (Department of Pharmacology and Toxicology,
University of Vienna). Cells were cultured in a humidified atmo-
sphere at 378C in growth medium consisting of DMEM, 10% fetal
calf serum, and 1% antibiotics (Invitrogen Corporation). Cells were
plated in growth medium at 30,000 cells/cm2 into culture dishes.
Cell Stimulation
The following day, gingival fibroblasts were exposed to a 20%
BCM or recombinant human TGF-b1 (PeproTech; Rocky Hill, NJ)
at 5 ng/mL in growth medium for 24 hours, before gene expression
analysis was performed. Supernatant was harvested, centrifuged,
and stored frozen until subjected for immunoassay. MC3T3-E1
cells were stimulated similarly, but instead for 72 hours, before
alkaline phosphatase was measured.
qRT-PCR Analysis and Immunoassay
Total RNA was isolated with the ExtractMe total RNA kit
(BLIRT S.A., Gdan´sk, Poland). Reverse transcription was per-
formed with SensiFAST cDNA (Bioline, London, UK). Polymerase
chain reaction was carried out with the SensiFAST SYBR ROX KitCopyright © 2018 Mutaz B. Habal, MD. Unautho
554(Bioline) on a 7500 Real-Time PCR System (both Applied Bio-
systems, Life Technologies Corporation, Carlsbad, CA). Primer
sequences are hIL11_F GGACAGGGAAGGGTTAAAGG,
hIL11_R GCTCAGCACGACCAGGAC; hPRG4_F CAGTTG-
CAGGTGGCATCTC, hPRG4_R TCGTGATTCAGCAAGTTT-
CATC; hNOX4_F TCTTGGCTTACCTCCGAGGA, hNOX4_R
CTCCTGGTTCTCCTGCTTGG; hActin_F CCAACCGCGA-
GAAGATGA; and hActin_R CCAGAGGCGTACAGGGATAG.
The mRNA levels were calculated by normalizing to the house-
keeping gene GAPDH using the DDCt method. For the immunoas-
say, the human IL-11 Quantikine ELISA kit was used (R&D
Systems).
Histochemical Staining
For alkaline phosphatase histochemistry, MC3T3-E1 cells were
fixed with neutral-buffered formalin and incubated with a substrate
solution containing naphthol AS-TR phosphate and fast blue BB
salt (Sigma, St. Louis, MO). After rinsing with distilled water,
cultures were photographed.
Micro Computed Tomography
Bone chips harvested from calvaria, mandible, and tibia were
subjected to micro computed tomography (mCT) with a voxel size
of 5mm using a SCANCO mCT 50 (Scanco Medical AG, Bru¨tti-
sellen, Switzerland). Scanning was done at 70 kV/100mAs and an
integration time of 500 milliseconds. Bone chips were visualized in
Amira 6.0.0 (FEI Company, Hillsboro, OR).
Statistics
Data represent the results of 3 independent preparations of BCM
exposed to 3 independent lines of gingiva fibroblasts ending up with
n¼ 6 for each group. The nonparametric Friedman test was used to
detect differences in treatment groups with a P< 0.05. No statistical
test was performed with the alkaline phosphatase histochemistry.
RESULTS
BCM From the 3 Preparations of Bone Chips
Increases Expression of TGF-b Target Genes
To determine whether bone chips harvested from calvaria,
mandible, and tibia have a similar paracrine-like activity, the
corresponding conditioned medium was subjected to bioassays.
As expected, BCM provoked a strong increase in the 3 TGF-b
target genes IL-11, NOX4, and PRG4. Based on the Friedman
analysis, BCM harvested from calvaria, mandible, and tibia equally
stimulated gene expression (Fig. 1, Table 1). In support of gene
expression, the immunoassay showed no significant differences inrized reproduction of this article is prohibited.
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TABLE 1. Relative Gene Expression of Gingival Fibroblasts Exposed to BCM
IL-11 Mean SD Median Min Max
TGF-b1 5.70 0.10 5.70 5.60 5.90
Calvaria-BCM 8.20 5.50 6.10 3.30 16.30
Mandible-BCM 8.10 1.60 7.60 6.80 11.30
Tibia-BCM 8.20 2.80 7.60 5.00 12.50
NOX4 Mean SD Median Min Max
TGF-b1 2.70 0.02 2.70 2.60 2.70
Calvaria-BCM 2.00 0.87 2.30 0.90 2.80
Mandible-BCM 3.00 0.52 3.00 2.30 3.60
Tibia-BCM 3.70 1.63 3.80 1.00 5.50
PRG4 Mean SD Median Min Max
TGF-b1 7.10 0.01 7.10 7.10 7.20
Calvaria-BCM 6.80 2.04 6.90 4.10 9.20
Mandible-BCM 8.60 1.05 8.60 7.20 10.40
Tibia-BCM 10.10 4.19 9.80 4.20 15.20
Gingival fibroblasts were exposed to BCM of different origins (calvaria, mandible,
and tibia). Recombinant femur and recombinant TGF-b1 (5 ng/mL) served as control.
Data represent the fold-change gene expression compared with unstimulated controls
of 3 independent experiments with fibroblasts from 2 donors (n¼ 6).
BCM, bone-conditioned medium; IL-11, interleukin 11; NOX4, NADPH oxidase 4;
PRG4, proteoglycan 4; SD, standard deviation.
TABLE 2. Total Human TGF-b1 of BCM
Preparation No 1 No 2 No 3
Calvaria-BCM 4.03 3.29 3.52
Mandible-BCM 3.01 3.71 3.82
Tibia-BCM 4.24 4.77 4.85
BCM was prepared from porcine bone from calvaria, mandible, and tibia. Data
represent the TGF-b1 amount in ng/mL of 3 independent preparations in total. Static
was performed based on a Friedman test with standard weighted-means analysis
P¼ 0.194.
BCM, bone-conditioned medium.
The Journal of Craniofacial Surgery  Volume 29, Number 3, May 2018 BCM From Various Bonesthe release of IL-11 into the supernatant of BCM stimulated human
gingival fibroblasts (Fig. 2). Taken together, these results, together
with the findings from the immunoassay, demonstrate that bone
chips harvested from different anatomic locations exhibit a similar
capacity to stimulate TGF-b target genes (Table 2).Copyright © 2018 Mutaz B. Habal, MD. Unautho
FIGURE 2. Bone-conditioned medium from the 3 preparations of bone chips
stimulates IL-11 protein production. Fibroblasts were exposed to conditioned
mediumprepared frombone chips harvested from calvaria, mandible, tibia, and
TGF-b1. IL-11 produced by the fibroblasts and released into the cell culture
medium was measured with an immunoassay. Data represent the results of
3 independent preparations of bone-conditioned medium exposed to 2
independent lines of gingiva fibroblasts ending up with n¼6 for each group.
The nonparametric Friedman test was used to detect differences in treatments
groups with a P<0.05. IL-11, interleukin 11.
# 2018 Mutaz B. Habal, MDBCM From the 3 Preparations of Bone Chips
Decreased Alkaline Phosphatase Activity
Next we exposed MC3T3-E1 cells to the BCM and determined
alkaline phosphatase activity. Figure 3 demonstrates that BCM
from bone chips harvested from calvaria, mandible, and tibia
equally suppressed alkaline phosphatase based on histochemical
staining. Thus, consistent with the findings of the gene expression
changes, histochemical staining of alkaline phosphatase activity
further supports the similar activity of BCMs harvested from
calvaria, mandible, and tibia.
Bone Chips From Diverse Bone Donor Sites
Have Different Morphology
We then sought a morphologic explanation for the similar TGF-
b activity of the respective BCMs. We have recently shown that
bone chips have a characteristic curled morphology.9 Thus, it isrized reproduction of this article is prohibited.
FIGURE 3. Bone-conditioned medium from the 3 preparations of bone chips
decreased alkaline phosphatase activity. Mouse MC3T3-E1 osteogenic cells
were exposed to conditioned medium prepared from bone chips harvested
from calvaria, mandible, and tibia. Alkaline phosphatase activity was
determined by histochemical staining. Data represent the results of 1 out of
2 independent experiments.
555
FIGURE 4. Micro computed tomography of 3 preparations of bone chips. Bone
chips from calvaria, mandible, and tibia were scanned by micro computed
tomography at an isotropic resolution of 5mm and visualized in Amira software.
Data represent the results of 1 out of 2 independent preparations of bone chips.
Hatami Kia et al The Journal of Craniofacial Surgery  Volume 29, Number 3, May 2018possible that also bone chips from other sites, including the calvaria
and the tibia, have a similar morphology. However, measurement of
the bone chips revealed considerable changes in morphology
(Fig. 4). The surface of bone chips from mandible and tibia
resembled broken sheets consisting of many flat connected bone
flakes. These flakes appeared to be larger in the bone chips from the
tibia compared with the mandible. Bone chips of the calvaria more
closely resembled a slice of trabecular bone without apparent
ruptures.
DISCUSSION
There is a widely held belief that the embryological origin and
ossification process affects the clinical performance of bone
grafts.4,11,12 This idea has prompted us to investigate the paracrine
activity of bone chips obtained from different sites—with the
calvaria and calvaria originating form ectodermal neural crest
and undergoing intramembranous ossification, while the tibia ori-
ginates from the lateral plate mesoderm where mesenchymal cells
form cartilage that undergoes endochondral bone formation.13,14
We have now found that the conditioned medium of bone chips
harvested from the calvaria, mandible, and tibia caused a compara-
ble increase in the TGF-b target genes IL-11, NOX4, and PRG4 in
oral fibroblasts. Likewise, the respective conditioned media of
calvaria, mandible, and tibia decreased alkaline phosphatase in
the osteogenic cell line MC3T3-E1 to a similar extent. The mor-
phology of the bone chips, however, varies noticeably. Together,
these findings establish that the paracrine-like activity of bone chips
is independent of embryological origin and the ossification process
of the donor site and the graft morphology.
If we relate the findings to those of others, we can refer to our
own data on BCM, all representing bone chips from pig mandi-
ble15–20 and mixed samples from human bone.30 Others have
focused on the cellular aspects related to bone chips from different
sources including from the mandibles.31 To study the paracrine-like
activity of fresh bone grafts from various sites, no comparative
research in vitro is available. Thus, we have to refer to clinical
studies describing the properties of grafts from different sites and
their impact on the process of graft consolidation and implant
survival; for example, atrophic jaws can be grafted with calvarial
bone blocks,1–4 mandibular bone blocks,3,32,33 and tibial bone
blocks.5,6 Studies on particulated bone grafts or bone chips were
performed in self-containing defect or with a titanium mesh, with
mandibular bone and tibia.34 Thus, there is evidence that bones
from different sources, all characterized by their cortical nature,
show a reliable performance in vivo. Our in vitro data, with
the limitation of the in vitro approach, support these clinical
observations.
Our findings that the morphology of the bone chips varies
considerably depending on the original bone source, were unex-
pected considering that the surface area of the bone chips would
influence the activity of the corresponding conditioned medium.Copyright © 2018 Mutaz B. Habal, MD. Unautho
556We originally performed the mCT to correlate the surface of the
bone chips with the TGF-b response. It would have been reasonable
to propose an association of the bone surface and the respective
TGF-b activity of the conditioned medium. However, the surface
characteristics were rather dissimilar at the nanoscale, so we had to
reject this aim. Since this was not the patient, it can be speculated
that fibroblasts are already stimulated at a maximum, even though
the BCM contains different amounts of TGF-b. Thus, future
research should focus on the half-maximal stimulation of TGF-b
target genes, rather than exposing cells to 20% BCM. We can thus
not rule out that the morphology of the bone chips affects the
activity of the conditioned medium. It would be attractive to
investigate the impact of the morphology of bone chips, obtained
from 1 source, on the activity of the respective conditioned medium
in vitro.
The clinical relevance of the present in vitro findings is limited
to the paracrine activity of the BCM and the selection of TGF-b
target genes, as well as the decrease in alkaline phosphatase activity.
Clearly, the model remains preliminary as other bone-derived
growth factors besides TGF-b also play a role during graft consoli-
dation, and these growth factors are not considered in our bioassay.
TGF-b also has isoforms; however, bone stores around 50-times
more TGF-b1 than TGF-b2.35 It has to be assumed that TGF-b
activity is an indicator for possible other factors since it was not the
intension of this research to study the myriad of factors in BCM 17
and their respective biological response in a bioassay.16 The clinical
relevance of the TGF-b activity released from bone chips, in
particular during the process of graft consolidation, remains a
matter of debate as long as we have no preclinical data. Neverthe-
less, the present in vitro study adds 1 piece to our understanding of
bone graft biology, particularly the impact of the anatomic site on
graft consolidation.
Future research should investigate the in vivo behavior of bone
grafts from different sources such as the calvaria, mandible, and
tibia; for example, using bone chips placed in 3-wall defect sites in
larger animals for simulations comparison.36 Other limitations
which should be addressed in future research are the process of
preparing the bone chips, which was a bone scraper in this study; so
possibly a bone mill may change the paracrine-like activity of the
bone chips. Moreover, specimens for fibroblasts were obtained
from 3 patients only. This is a minor limitation because they were
used as a bioassay with 3 independent preparations of bone condi-
tioned medium, together resulting in 9 data points allowing a robust
statistical analysis. Also the question as to whether the time between
animal euthanasia and the preparation of the bone chips affects the
release of TGF-b activity requires further research. Another point of
critique may be the cross-species study design. We do not consider
this a problem since particular TGF-b is conserved among the
species and the bioassays are sensitive and therefore appropriate for
our purpose. Ideally, fibroblasts of porcine origin could have been
used; however, we have established our system with cells of human
origin. This research can be extended to the preparation of condi-
tioned medium from allogenic bone, including demineralized
freeze-dried bone, which also holds a TGF-b activity to be released
in a similar setting.37,38 Thus, the present in vitro data should be
interpreted with care and the translation of the bioassay into a
predictable in vivo response requires additional research. Thus, for
the evaluation of bone graft performance a preclinical or even a
randomized controlled clinical trial in humans can be proposed.
In conclusion, the findings presented here indicate that bone
chips with a different embryological origin release a similar TGF-
b1 activity. Therefore, impact of the embryological origin on
the clinical performance of bone grafts cannot be explained by a
differential release of TGF-b activity.rized reproduction of this article is prohibited.
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